However, no significant differences were found in menstrual regularity among the groups, suggesting that while this herbal blend may support metabolic health, its effects on reproductive function remain unclear
If youre uncertain about which supplement is right for you, we encourage you to take our AI quiz to determine the best options tailored to your wellness journey
On the contrary, those prioritizing weight loss might find Wegovy or Mounjaro more suitable, with Mounjaro offering a dual-action mechanism that could present an edge for certain patients
Although all unimolecular triple agonists in phase 2 trials for obesity are GLP1/GIP/GCG triple agonists, there is an ongoing phase 2 clinical trial of bioglutide, an oral insulin-like-growth factor-1 (IGF-1)/GLP-1/GIP/GCG quadruple agonist (NCT06564753) for individuals with obesity, which is also being trialled in combination with tirzepatide (NCT06643728)
Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 drugs
The fundamental drivers of this expansion are rooted in the molecule's versatility